Fosaprepitant Intravenous and Omadacycline Tosylate
Determining the interaction of Fosaprepitant Intravenous and Omadacycline Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Intravenous-Omalizumab
- Fosaprepitant Intravenous-Omalizumab Subcutaneous
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, and Ritonavir
- Fosaprepitant Intravenous-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Fosaprepitant Intravenous-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Omadacycline Tosylate-Foscarnet
- Omadacycline Tosylate-Foscarnet Intravenous
- Omadacycline Tosylate-Foscarnet Sodium
- Omadacycline Tosylate-Foscavir
- Omadacycline Tosylate-Fosfomycin
- Omadacycline Tosylate-Fosfomycin Tromethamine